Related Experiment Videos
Chemical teratogenesis in humans: biochemical and molecular mechanisms
1Department of Pharmacology, School of Medicine, University of Washington, Seattle 98195, USA.
Abstract:
In this review, an attempt has been made to summarize our current understanding of the mechanisms whereby certain chemicals cause birth defects. The chemicals selected for consideration were those that have been designated as established or recognized human teratogens. It is clear that our current understanding of mechanisms whereby these agents cause teratogenic effects (birth defects) can vary dramatically from one agent to the next. Extremes include the folic acid antagonists, which are now well established as agents that produce birth defects by virtue of potent inhibition of dihydrofolate reductase as a primary biochemical mechanism. An example at the other extreme is ethanol, for which very few definitive statements can be made with regard to teratogenic mechanisms, and the probability exists that a large number of interacting, contributory mechanisms can be invoked. For nearly all chemical teratogens, the critical links in the chains of events between the initial, primary biochemical and molecular mechanistic event (e.g. dihydrofolate reductase inhibition) and the manifestations of specific abnormalities (pathogenic mechanisms) remain to be delineated. This will provide an enormous challenge for investigators for years to come.
Insights
Understanding how chemicals cause birth defects is complex. While some teratogens like folic acid antagonists have clear mechanisms, others like ethanol involve multiple interacting factors.
Area of Science:
- Toxicology
- Developmental Biology
- Pharmacology
Background:
- Established human teratogens are chemicals known to cause birth defects.
- The mechanisms by which these teratogens exert their effects are diverse and not fully understood.
Purpose of the Study:
- To review and summarize the current understanding of the mechanisms of teratogenesis for recognized human teratogens.
- To highlight the variability in mechanistic understanding across different chemical agents.
Main Methods:
- Literature review of established human teratogens.
- Analysis of documented biochemical and molecular mechanisms of teratogenicity.
- Comparison of mechanistic pathways for different classes of teratogens.
Main Results:
- Mechanisms vary significantly among teratogens.
- Folic acid antagonists demonstrate a clear mechanism via dihydrofolate reductase inhibition.
- Ethanol's teratogenic mechanisms are poorly defined, likely involving multiple interacting factors.
Conclusions:
- The link between primary molecular events and specific birth defects remains largely undelineated for most chemical teratogens.
- Further research is needed to elucidate the complex pathways leading to teratogenic outcomes.
- Understanding these mechanisms presents a significant challenge for future scientific investigation.